ArticleESMO gastrointestinal oncology2026

BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer.

T Wakatsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.